HIGH-TITER HIV-1 NEUTRALIZING ANTIBODY-RESPONSE OF RHESUS MACAQUES TO GP160 AND ENV PEPTIDES

被引:10
|
作者
RONCO, J
DEDIEU, JF
MARIE, FN
PINTER, A
KACZOREK, M
GIRARD, M
机构
[1] INST PASTEUR,DEPT VIROL,MOLEC VIROL LAB,CNRS,URA 545,28 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE
[2] PASTEUR MERIEUX SERUMS & VACCINS,PARC IND INCARVILLE,F-27101 VAL DE REUIL,FRANCE
[3] PROTEINE PERFORMANCE,F-75018 PARIS,FRANCE
[4] PUBL HLTH RES INST CITY NEW YORK INC,NEW YORK,NY 10016
关键词
D O I
10.1089/aid.1992.8.1117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three groups of four rhesus macaques were immunized twice, one month apart with purified recombinant HIV-1LAI gp160 in the presence of either alum, incomplete Freund's adjuvant (IFA), or SAF-1. Two months later, the animals were injected twice again with a synthetic peptide with the sequence of the principal neutralization determinant (PND) of the HIV-1LAI isolate mixed with the same adjuvants. All animals received a booster injection of gp160 and PND peptide at 6 months. This regimen of immunization induced in the SAF-1 and IFA groups a high-titer neutralizing antibody response that declined progressively over the course of the following 6 months. In contrast, only a weak response was observed in the alum group. Neutralizing antibody titers varied as anti-PND titers, suggesting that they were principally targeted to the PND. A shortened immunization protocol comprising two injections of gp160 at 0 and 1 month followed by one injection of PND peptide at 3 months is suggested as optimal for the induction of high titers of HIV-1 neutralizing antibodies in primates.
引用
收藏
页码:1117 / 1123
页数:7
相关论文
共 50 条
  • [41] Characterization and enhancement of the interaction between HIV-1 gp120/gp160 and MBL
    Hart, ML
    Saifuddin, M
    Spear, GT
    FASEB JOURNAL, 2001, 15 (04): : A691 - A691
  • [42] HIGH-TITER PLASMA VIREMIA IN ACUTE HIV-1 INFECTION
    SAAG, MS
    CLARK, SJ
    KAPPAS, JC
    HAHN, BH
    SHAW, GM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 315 - 316
  • [43] ANTIBODY FINE SPECIFICITY TO HIV-1 GP160 EPITOPES IN GROUPS OF HIV-1 INFECTED INDIVIDUALS AND CORRELATION WITH CLINICAL-DISEASE PROGRESSION
    WONG, MT
    WARREN, RQ
    ANDERSON, SA
    DOLAN, MJ
    MELCHER, GP
    BOSWELL, RN
    KENNEDY, RC
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A241 - A241
  • [44] HUMORAL RESPONSE IN RABBITS IMMUNIZED WITH CALCIUM-PHOSPHATE ADJUVANTED HIV-1 GP160 ANTIGEN
    RELYVELD, E
    CHERMANN, JC
    BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (02) : 79 - 83
  • [45] HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
    DEPALMA, L
    PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1995, 6 (02): : 97 - 98
  • [46] IMMUNIZATION WITH RECOMBINANT GP160 PROLONGS THE SURVIVAL OF HIV-1 TRANSGENIC MICE
    SHIRAI, A
    KLINMAN, DM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (10) : 979 - 983
  • [47] Single Glycan Binding by a Broadly Neutralizing Antibody to HIV-1 Env
    Garces, F.
    Sok, D.
    Kim, H. J.
    McBride, R.
    Kong, L.
    Hua, Y.
    Paulson, J. C.
    Ward, A. B.
    Burton, D. R.
    Wilson, I. A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A187 - A187
  • [48] Genotypic Characterization of HIV Type 1 env gp160 Sequences from Three Regions in Thailand
    de Silva, U. Chandimal
    Warachit, Jiranan
    Sattagowit, Nerisa
    Jirapongwattana, Chanin
    Panthong, Sumolrat
    Utachee, Piraporn
    Yasunaga, Teruo
    Ikuta, Kazuyoshi
    Kameoka, Masanori
    Boonsathorn, Naphatsawan
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (02) : 223 - 227
  • [49] Vertical HIV-1 transmission: Importance of neutralizing antibody titer and specificity
    Bongertz, V
    Costa, CI
    Veloso, VG
    Grinsztejn, B
    Joao, EC
    Calvet, G
    Pilotto, JH
    Guimaraes, ML
    Morgado, MG
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2001, 53 (03) : 302 - 309
  • [50] Immunization with HIV-1 gp160 by the ''prime and boost'' regimen protects macaques against SHIV HXBc2 challenge
    Hu, SL
    Klaniecki, J
    Travis, BM
    Wrey, T
    Pennathur, S
    Montefiori, DC
    Thompson, JL
    Agy, MB
    Kuller, L
    Morton, WR
    VACCINES 97 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1997, : 291 - 298